within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03F_ProgestogensAndEstrogensInCombination.G03FB09_LevonorgestrelAndEstrogen;
model LevonorgestrelAndEstrogen 
   extends Pharmacolibrary.Drugs.ATC.G.G03FB09;

  annotation(Documentation(
    info ="<html><body><p>Levonorgestrel and estrogen are used in combination as oral contraceptives for the prevention of pregnancy. The combination is widely used and approved for contraceptive purposes in many countries. Levonorgestrel is a synthetic progestogen, while estrogen (usually ethinylestradiol) is a synthetic estrogen component.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated for a typical healthy adult non-pregnant female, population for oral combined hormonal contraceptive use. No direct reference describing full compartmental PK parameters for the specific combination with ATC code G03FB09 was found.</p><h4>References</h4><ol><li><p>Moreira de Brito, C, et al., &amp; Cercato, C (2021). Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery. <i>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</i> 17(4) 673–681. DOI:<a href=&quot;https://doi.org/10.1016/j.soard.2020.12.007&quot;>10.1016/j.soard.2020.12.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33547015/&quot;>https://pubmed.ncbi.nlm.nih.gov/33547015</a></p></li><li><p>Stanczyk, FZ, et al., &amp; Archer, DF (2024). Comparison of estrogenic components used for hormonal contraception. <i>Contraception</i> 130 110310–None. DOI:<a href=&quot;https://doi.org/10.1016/j.contraception.2023.110310&quot;>10.1016/j.contraception.2023.110310</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37863464/&quot;>https://pubmed.ncbi.nlm.nih.gov/37863464</a></p></li><li><p>Jordy, AB, et al., &amp; Bækdal, TA (2021). Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects. <i>Clinical pharmacokinetics</i> 60(9) 1171–1185. DOI:<a href=&quot;https://doi.org/10.1007/s40262-020-00976-x&quot;>10.1007/s40262-020-00976-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33782832/&quot;>https://pubmed.ncbi.nlm.nih.gov/33782832</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end LevonorgestrelAndEstrogen;
